Why the study?
Does amlodipine, benazepril, or their combination improve biochemical components and myocardial performance after reversal of left ventricular hypertrophy in spontaneously hypertensive rats?
Population
Male spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats, aged 19 weeks
Comparison
Amlodipine, benazepril, or combination for 3 weeks vs Vehicle
Design
Preclinical
Follow-up
3 weeks
Authors
Loading...
Does not support immediate practice changes; leaves open translation of combination benefits in hypertensive rat models to clinical LVH reversal.
Does amlodipine, benazepril, or their combination improve biochemical components and myocardial performance after reversal of left ventricular hypertrophy in spontaneously hypertensive rats?
Amlodipine, benazepril, and their combination reverse left ventricular hypertrophy in spontaneously hypertensive rats without increasing fibrous tissue or impairing left ventricular performance, while combination therapy prevents amlodipine-induced right ventricular mass increase.
Arita et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: